- Home
- applications
- denmark
- neurology
Show results for
Refine by
Neurology Applications For The Served Medical Health Care Industry Available In In Denmark
89 applications found
GRFT-R02 is a unique, highly osteogenic putty. This patented biomaterial is expected to allow surgeons to address difficult surgical situations like acetabular reconstruction, spinal postero-lateral fusion, non-union or complex cases of fracture healing with poor vascularization. GRFT-R02 shows osteoinductive properties to enhance bone regeneration and is able to repair a critical and segmental bone defects in animal ...
ByGraftys based in AIX EN PROVENCE Cedex 3, FRANCE
The Body’s Built In Pain And Inflammation Defense System. There are a number of pain defense systems that operate in our body. One of them is called the Endocannabinoid System or ECS for short. The ECS is a part of the body’s built in pain and inflammation defense system and there are a number of receptors that make up this system. The two major types of receptors in the ECS are called CB1 and CB2 ...
ByTetra Bio-Pharma based in Orleans,, ONTARIO (CANADA)
Degenerative disc disease is a chronic and progressive condition that is characterized by inflammation and breakdown of tissue within the intervertebral disc. Located between the vertebral bones in the spine, the intervertebral disc acts like a pillow to cushion and evenly distribute pressure across the vertebrae. Each disc is comprised of an outer fibrous ring, the annulus fibrosus, which surrounds an inner gel-like center, the nucleus pulposus. ...
ByDiscGenics, Inc. based in Salt Lake City, UTAH (USA)
The success of ultrasound imaging for needle placement in Central Line Insertions, Regional Anesthesia and Pain Management is well documented. Ultrasound is non-invasive and offers significant benefits in the quality of care by reducing complications and increasing safety. The eZono®5000 portable ultrasound device offers excellent imaging with needle guidance and education ...
ByeZono AG based in Jena, GERMANY
Current practice acknowledges that a reduction in venous stasis of the lower limb reduces DVT incidence in acute stroke patients1. It is also recognised that DVT is a blood clot that most commonly forms in the deep veins of the ...
ByFirstkind Ltd based in High Wycombe, UNITED KINGDOM
Due to its ability to overlay ICG angiographies and FA images for precise planning, Navilas provides a unique and advanced treatment paradigm for central serous chorioretinopathy. In conjunction with the ability to perform subthreshold treatments Navilas represents an optimal tool to target central serous ...
ByOD-OS GmbH based in Teltow, GERMANY
Thermal Management: Pyroid HT pyrolytic graphite thermal spreaders and thermal vias are a powerful new material solution in the battle against thermal heat in state-of-the-art electronic circuits and devices. HT material matches the heat spreading capability of CVD diamond at 1700 W/mK but at substantially better economics. ...
ByCETCO based in New York, NEW YORK (USA)
Glaucoma is a group of diseases that damage the eye’s optic nerve and can, if left untreated, cause vision impairment and even blindness. Glaucoma is asymptomatic (meaning it occurs without noticeable symptoms appearing). It can often go undiagnosed without proper check-ups and can get worse over time. Although the development of glaucoma is not completely understood, we do know that it damages the nerve fibers in the optic nerve and in the retina, limiting a person’s field of view and quality of ...
ByGlaukos Corporation based in San Clemente, CALIFORNIA (USA)
Mild Cognitive Impairment (MCI) is a clinical condition that affects one or more cognitive domains (memory, language, concentration). Nearly 900 thousand Italians are affected by it and it is prevalent from the age of 60. It is the first indicator of a disease that can become increasingly disabling and compound over time, increasing the risk of dementia. It is the transitional phase between normal aging and dementia, during which it is possible to intervene and delay the onset of the ...
ByNeopharmed Gentili S.p.A. based in Milano, ITALY
Addressing the many sides of depression, the Flow treatment consists of a brain stimulation headset that targets the physical root-cause of depression and a behavioural therapy app to address the psychological and environmental ...
ByFlow Neuroscience AB based in Malmö, SWEDEN
Dense HA has been shown to be effective for soft tissue augmentation applications. The high density and chemical purity minimize the rate of resorption of the augmentation and result in a more durable construct. Applications include sphincter muscle augmentation for such diverse problems as urinary incontinence, vocal fold augmentation to help stroke victims regain speaking ability and for cosmetic ...
ByCaP Biomaterials, LLC based in East Troy, WISCONSIN (USA)
Neurological impairments such as strokes, spinal cord injuries, traumatic brain injuries, cerebral palsy, multiple sclerosis, and Parkinson’s disease can significantly affect a patient’s mobility, and many patients affected with these conditions have a significant long-term mobility impairment. One of the main challenges of existing neuro-rehabilitation treatment methods is effectively preserving or reestablishing the coordination between motricity (active movement) and the related neurosensory ...
ByTechno Concept based in Manosque, FRANCE
Glaukos is developing multiple micro-invasive, bioerodible, sustained-release drug delivery platforms designed to be used in the treatment of various retinal disease, including age-related macular degeneration (AMD) and diabetic macular ...
ByGlaukos Corporation based in San Clemente, CALIFORNIA (USA)
Coronary artery disease (CAD), also known as coronary heart disease, is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. According to the American Heart Association, CAD affects over 13 million Americans and accounts for over 650,000 deaths ...
ByQT Vascular Ltd. based in , SINGAPORE
Kirkstall’s Quasi Vivo® system aims to establish and optimise a human in vitro 3D Blood Brain Barrier (BBB) in an effort to identify important mechanistic pathways for successful biomarker analysis, drug delivery and toxicity ...
ByKirkstall Ltd. based in York, UNITED KINGDOM
The information on this page is intended for Physicians. ReActiv8 is an effective and durable treatment for your patients with mechanical Chronic Low Back Pain (CLBP) and multifidus muscle dysfunction. ...
ByMainstay Medical based in Dublin 2, IRELAND
Diabetes occurs when glucose (sugar) builds up in the blood. This buildup causes an inability of the body to use the glucose for energy. This inability happens when the insulin does not function correctly. Many people believe that diabetes is a “sugar problem” but it is actually an “insulin ...
ByProdigy Diabetes Care, LLC based in Charlotte, NORTH CAROLINA (USA)
Functional ultrasound (fUS) imaging is emerging as a powerful tool in neuropharmacology to study the effects of drugs on brain activity. Unlike fMRI, fUS offers increased sensitivity and compatibility with awake animal models, providing an unbiased view of drug interactions with neural substrates. Recent studies by Theranexus have utilized fUS to observe the hemodynamic response to different pharmacological interventions, such as the combination of donepezil and mefloquine, which target acetylcholinesterase ...
ByIconeus based in Paris, FRANCE
Iconeus is leveraging its expertise in preclinical research to develop innovative clinical applications using its Iconeus One CR functional ultrasound system. This system is instrumental for transcranial ultrasound localization microscopy (ULM), allowing for the imaging of the brain's microvasculature at a microscopic resolution, which is particularly beneficial for diagnosing and monitoring stroke and aneurysm. The system's current projects, in collaboration with entities like Geneva University and Physics for ...
ByIconeus based in Paris, FRANCE
This website is designed to assist patients, family members, and caregivers in obtaining valuable information about the EMAGINE study, and to support the process of eligibility evaluation, and research study enrollment for potential participants. The BQ 2.0 system (designed and manufactured by BrainQ Technologies Ltd.) is an investigational device, meaning it has not been approved by the FDA, the use of which has had no related adverse events to date. ...
ByBrainQ Technologies based in Jerusalem, ISRAEL